Literature DB >> 29514064

Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.

Luis Rajman1, Karolina Chwalek1, David A Sinclair2.   

Abstract

Nicotinamide adenine dinucleotide (NAD), the cell's hydrogen carrier for redox enzymes, is well known for its role in redox reactions. More recently, it has emerged as a signaling molecule. By modulating NAD+-sensing enzymes, NAD+ controls hundreds of key processes from energy metabolism to cell survival, rising and falling depending on food intake, exercise, and the time of day. NAD+ levels steadily decline with age, resulting in altered metabolism and increased disease susceptibility. Restoration of NAD+ levels in old or diseased animals can promote health and extend lifespan, prompting a search for safe and efficacious NAD-boosting molecules that hold the promise of increasing the body's resilience, not just to one disease, but to many, thereby extending healthy human lifespan.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD38; PARP1; STAC; aging; cancer; cardiovascular disease; chromatin; epigenetics; inflammation; nicotinamide mononucleotide; nicotinamide riboside; sirtuins

Mesh:

Substances:

Year:  2018        PMID: 29514064      PMCID: PMC6342515          DOI: 10.1016/j.cmet.2018.02.011

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  252 in total

1.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

Review 2.  Enzymology of NAD+ synthesis.

Authors:  G Magni; A Amici; M Emanuelli; N Raffaelli; S Ruggieri
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1999

3.  NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.

Authors:  Yujun Hou; Sofie Lautrup; Stephanie Cordonnier; Yue Wang; Deborah L Croteau; Eduardo Zavala; Yongqing Zhang; Kanako Moritoh; Jennifer F O'Connell; Beverly A Baptiste; Tinna V Stevnsner; Mark P Mattson; Vilhelm A Bohr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

4.  Metabolic fate of extracellular NAD in human skin fibroblasts.

Authors:  M F Aleo; M L Giudici; S Sestini; P Danesi; G Pompucci; A Preti
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

5.  Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function.

Authors:  Lori Klaidman; Maria Morales; Seyha Kem; Jun Yang; Mei-Ling Chang; James D Adams
Journal:  Pharmacology       Date:  2003-11       Impact factor: 2.547

6.  Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.

Authors:  Ping K Chan; Raul Torres; Cihangir Yandim; Pui P Law; Sanjay Khadayate; Marta Mauri; Crina Grosan; Nadine Chapman-Rothe; Paola Giunti; Mark Pook; Richard Festenstein
Journal:  Hum Mol Genet       Date:  2013-03-07       Impact factor: 6.150

7.  Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells.

Authors:  Federica Zamporlini; Silverio Ruggieri; Francesca Mazzola; Adolfo Amici; Giuseppe Orsomando; Nadia Raffaelli
Journal:  FEBS J       Date:  2014-10-04       Impact factor: 5.542

8.  P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury.

Authors:  Terry C Yin; Jeremiah K Britt; Héctor De Jesús-Cortés; Yuan Lu; Rachel M Genova; Michael Z Khan; Jaymie R Voorhees; Jianqiang Shao; Aaron C Katzman; Paula J Huntington; Cassie Wassink; Latisha McDaniel; Elizabeth A Newell; Laura M Dutca; Jacinth Naidoo; Huxing Cui; Alexander G Bassuk; Matthew M Harper; Steven L McKnight; Joseph M Ready; Andrew A Pieper
Journal:  Cell Rep       Date:  2014-09-15       Impact factor: 9.423

9.  Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden.

Authors:  P A Fall; M Fredrikson; O Axelson; A K Granérus
Journal:  Mov Disord       Date:  1999-01       Impact factor: 10.338

10.  Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.

Authors:  Carlos Escande; Veronica Nin; Nathan L Price; Verena Capellini; Ana P Gomes; Maria Thereza Barbosa; Luke O'Neil; Thomas A White; David A Sinclair; Eduardo N Chini
Journal:  Diabetes       Date:  2012-11-19       Impact factor: 9.461

View more
  187 in total

1.  SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.

Authors:  Giovanna Sociali; Alessia Grozio; Irene Caffa; Susanne Schuster; Pamela Becherini; Patrizia Damonte; Laura Sturla; Chiara Fresia; Mario Passalacqua; Francesca Mazzola; Nadia Raffaelli; Antje Garten; Wieland Kiess; Michele Cea; Alessio Nencioni; Santina Bruzzone
Journal:  FASEB J       Date:  2018-12-04       Impact factor: 5.191

2.  Extracellular signal-regulated kinase 1/2 regulates NAD metabolism during acute kidney injury through microRNA-34a-mediated NAMPT expression.

Authors:  Justin B Collier; Rick G Schnellmann
Journal:  Cell Mol Life Sci       Date:  2019-12-23       Impact factor: 9.261

3.  The Emergence of the Nicotinamide Riboside Kinases in the regulation of NAD+ Metabolism.

Authors:  Rachel S Fletcher; Gareth Lavery
Journal:  J Mol Endocrinol       Date:  2018-05-30       Impact factor: 5.098

Review 4.  Mitochondrial fidelity and metabolic agility control immune cell fate and function.

Authors:  Michael N Sack
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

5.  Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway.

Authors:  Igor Shats; Jason G Williams; Juan Liu; Mikhail V Makarov; Xiaoyue Wu; Fred B Lih; Leesa J Deterding; Chaemin Lim; Xiaojiang Xu; Thomas A Randall; Ethan Lee; Wenling Li; Wei Fan; Jian-Liang Li; Marina Sokolsky; Alexander V Kabanov; Leping Li; Marie E Migaud; Jason W Locasale; Xiaoling Li
Journal:  Cell Metab       Date:  2020-03-03       Impact factor: 27.287

6.  Dihydronicotinamide riboside is a potent NAD+ concentration enhancer in vitro and in vivo.

Authors:  Yue Yang; Farheen Sultana Mohammed; Ning Zhang; Anthony A Sauve
Journal:  J Biol Chem       Date:  2019-04-04       Impact factor: 5.157

Review 7.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

8.  Adipose tissue NAD+ biosynthesis is required for regulating adaptive thermogenesis and whole-body energy homeostasis in mice.

Authors:  Shintaro Yamaguchi; Michael P Franczyk; Maria Chondronikola; Nathan Qi; Subhadra C Gunawardana; Kelly L Stromsdorfer; Lane C Porter; David F Wozniak; Yo Sasaki; Nicholas Rensing; Michael Wong; David W Piston; Samuel Klein; Jun Yoshino
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-06       Impact factor: 11.205

Review 9.  Mitochondrial pathways in human health and aging.

Authors:  Rebecca Bornstein; Brenda Gonzalez; Simon C Johnson
Journal:  Mitochondrion       Date:  2020-07-30       Impact factor: 4.160

Review 10.  Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases.

Authors:  Alice E Kane; David A Sinclair
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.